Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:2371-2375

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaposzta, Z.
Right arrow Articles by Markus, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaposzta, Z.
Right arrow Articles by Markus, H. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
Medline Plus Health Information
*Blood Thinners
Related Collections
Right arrow Embolic stroke
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Antiplatelets

(Circulation. 2001;103:2371.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

L-Arginine and S-Nitrosoglutathione Reduce Embolization in Humans

Zoltan Kaposzta, MD; Paul A. Baskerville, FRCS; David Madge, PhD; Simon Fraser, FRCS; John F. Martin, FRCP; Hugh S. Markus, FRCP

From Clinical Neuroscience, St George’s Hospital Medical School (Z.K., H.S.M.); Department of Vascular Surgery, King’s College Hospital (S.F., P.A.B); and Cardiovascular Medicine, University College of London (D.M., J.F.M.), London, UK.

Correspondence to Professor Hugh Markus, Clinical Neuroscience, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. E-mail h.markus{at}sghms.ac.uk

BackgroundL-Arginine reduces platelet aggregation and adhesion in ex vivo studies, but there is no evidence as yet that it has a therapeutic effect on clinical end points. Doppler ultrasound can detect cerebral emboli noninvasively. Such embolic signals are common after carotid endarterectomy, and their frequency predicts risk of stroke recurrence. We used this situation to determine the antiplatelet efficacy of L-arginine and S-nitrosoglutathione (GSNO), a physiological nitric oxide donor with possible platelet specificity.

Methods and Results—Patients undergoing carotid endarterectomy were randomized in a double-blind manner between L-arginine (n=14), GSNO (n=14), or placebo (n=14) administered intravenously for 90 minutes, starting 30 minutes after skin closure. All patients were pretreated with aspirin and given heparin during surgery. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 4 hours after surgery, beginning 30 minutes after skin closure, and also at 6 and 24 hours. There were highly significant reductions in the number of Doppler embolic signals in the L-arginine and GSNO groups; first 4 hours, median (range) number of embolic signals, placebo 44.7 (6 to 778), L-arginine 9.5 (0 to 225), and GSNO 0.8 (0 to 8), both P<0.001 versus control values. The reduction in the signals persisted at the 24-hour recording.

Conclusions—Intravenous L-arginine and GSNO attenuate Doppler embolic signals in humans. Modulation of the NO system with these agents may have applications in the treatment of thromboembolic disease. This study demonstrates the potential application of ultrasonic embolic signal detection to examine the efficacy of new antiplatelet agents in relatively small numbers of patients.


Key Words: ultrasonics • drugs • platelets • inhibitors • carotid arteries




This article has been cited by other articles:


Home page
StrokeHome page
J. T. Kielstein, F. Donnerstag, S. Gasper, J. Menne, A. Kielstein, J. Martens-Lobenhoffer, F. Scalera, J. P. Cooke, D. Fliser, and S. M. Bode-Boger
ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans
Stroke, August 1, 2006; 37(8): 2024 - 2029.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm
Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Heiss, P. Kleinbongard, A. Dejam, S. Perre, H. Schroeter, H. Sies, and M. Kelm
Acute Consumption of Flavanol-Rich Cocoa and the Reversal of Endothelial Dysfunction in Smokers
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1276 - 1283.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. D. Aronow, M. Shishehbor, D. A. Davis, I. L. Katzan, D. L. Bhatt, C. T. Bajzer, A. Abou-Chebl, K. W. Derk, P. L. Whitlow, and J. S. Yadav
Leukocyte Count Predicts Microembolic Doppler Signals During Carotid Stenting: A Link Between Inflammation and Embolization
Stroke, September 1, 2005; 36(9): 1910 - 1914.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. S. Markus and A. MacKinnon
Asymptomatic Embolization Detected by Doppler Ultrasound Predicts Stroke Risk in Symptomatic Carotid Artery Stenosis
Stroke, May 1, 2005; 36(5): 971 - 975.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Vilahur, E. Segales, E. Salas, and L. Badimon
Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model
Circulation, September 21, 2004; 110(12): 1686 - 1693.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al.
Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, May 11, 2004; 62(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Vilahur, M. I. Baldellou, E. Segales, E. Salas, and L. Badimon
Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects
Cardiovasc Res, March 1, 2004; 61(4): 806 - 816.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Kaposzta, A. Clifton, J. Molloy, J. F. Martin, and H. S. Markus
S-Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty
Circulation, December 10, 2002; 106(24): 3057 - 3062.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. L. Stork, C. R. Levi, B. R. Chambers, A. L. Abbott, and G. A. Donnan
Possible Determinants of Early Microembolism After Carotid Endarterectomy
Stroke, August 1, 2002; 33(8): 2082 - 2085.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Tousoulis, C. Tentolouris, and P. Toutouzas
L-Arginine and Thrombosis
Circulation, December 18, 2001; 104 (25): e159 - e159.
[Full Text] [PDF]


Home page
CirculationHome page
J. C. Grotta and A. V. Alexandrov
Preventing Stroke : Is Preventing Microemboli Enough?
Circulation, May 15, 2001; 103(19): 2321 - 2322.
[Full Text] [PDF]


Home page
CirculationHome page
Z. Kaposzta, J. F. Martin, and H. S. Markus
Switching off Embolization From Symptomatic Carotid Plaque Using S-Nitrosoglutathione
Circulation, March 26, 2002; 105(12): 1480 - 1484.
[Abstract] [Full Text] [PDF]